Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care    » Alternative Medicine    » Care    » Cats    » Children    » Dental    » Dogs    » Elderly    » Eye    » Hospital    » Monitor    » Pets    » Pregnancy    » Self-Management    » Support Systems    » Surgery    » Traditional Medicine Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Care » Monitor

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

MannKind Inhaled Insulin Matches Injections -Study Posted: Thursday, September 21, 2006

An inhaled insulin being developed by MannKind Corp produces comparable improvements in blood sugar control to rapid-acting insulin analog (RAA) given by injection, researchers said on Saturday.

The Earlier You Get Diabetes, The Worse it Will Get Posted: Thursday, September 21, 2006

People who develop type 2 diabetes when they're younger than 50 years of age are more likely to experience a worsening of their disease than those diagnosed at an older age.

Optimizing Control in Diabetes (OPTIMIZE) Survey Urges Action NOW! Posted: Thursday, September 21, 2006

Diabetes experts have warned that urgent action needs to be taken to drastically improve the management of diabetes to prevent a potentially devastating and costly global burden.

Pioglitazone Demonstrates Significant Improvements in Cardiovascular Outcomes Posted: Thursday, September 21, 2006

Actos® (pioglitazone HCl), an oral antidiabetic medication, demonstrated significant cardiovascular benefits in reducing the risk of heart attack and/or stroke and acute coronary syndrome in patients with type 2 diabetes.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 2- Ramipril Arm) Posted: Thursday, September 21, 2006

The Dream Study also found that the ACE-inhibitor Altace (ramipril) does not prevent type 2 diabetes in patients with impaired glucose metabolism.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 1-Rosiglitazone Arm) Posted: Thursday, September 21, 2006

The results of a major study released: The Dream Study (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) with over 5000 patients Rosiglitazone reduced the risk of developing type 2 diabetes by 62 percent (p<0.0001) relative to placebo among people at high risk of developing type 2 diabetes.

Significant Glucose-Lowering Efficacy Of JANUVIA™ in Phase III Study Posted: Thursday, September 21, 2006

New data presented for the first time at the 42nd annual meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen demonstrated a mean reduction in A1C of 2.1% from a mean baseline A1C of 8.8% and a reduction of 2.9% for those with a mean A1c of 11.2%.

Galvus® Demonstrates Powerful Blood Sugar Reductions In Phase III Studies Posted: Thursday, September 21, 2006

Galvus dropped A1c by 1.8% without weight gain.

Overweight Youths Should be Treated for Obesity Much Earlier to Prevent Diabetes Posted: Wednesday, September 13, 2006

Watchful waiting when faced with overweight preschoolers and elementary school children is poor pediatric practice.

Adherence to Preventive Medications Reduces Risk of Diabetes Posted: Wednesday, September 13, 2006

Participants who were compliant had a 38.2% reduced risk of developing diabetes.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.